You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serine Proteinase Inhibitors

Showing 1 - 25 of 4,398
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))

Recruiting
  • Alpha1-Antitrypsin Deficiency
  • Alpha-1 15%
  • Liquid Alpha1-Proteinase Inhibitor (Human)
  • Gainesville, Florida
  • +5 more
Jan 13, 2023

Eosinophilic Esophagitis Trial (Alpha-proteinase inhibitor)

Not yet recruiting
  • Eosinophilic Esophagitis
  • Alpha-proteinase inhibitor
  • (no location specified)
Aug 2, 2022

Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia

Not yet recruiting
  • Granulomatosis With Polyangiitis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Dec 29, 2022

HIV Disease Trial in New York (alpha-1-Proteinase Inhibitor)

Completed
Has Results
  • HIV Disease
  • alpha-1-Proteinase Inhibitor
  • New York, New York
    Cabrini Medical Center
Aug 31, 2021

GVHD, Bone Marrow Transplant Failure, Alpha 1-Antitrypsin Trial in Israel

Active, not recruiting
  • GVHD
  • +2 more
    • Jerusalem, Center, Israel
    • +3 more
    Mar 9, 2021

    COPD (COPD), Alpha1-Antitrypsin Deficiency Trial (ARALAST NP, Another Available A1PI)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Alpha1-Antitrypsin Deficiency
    • ARALAST NP
    • Another Available A1PI
    • (no location specified)
    Jul 18, 2022

    COVID-19 Trial in Worldwide (Liquid Alpha1-Proteinase Inhibitor (Human), Placebo, Standard Medical Treatment)

    Terminated
    • COVID-19
    • Liquid Alpha1-Proteinase Inhibitor (Human)
    • +2 more
    • Birmingham, Alabama
    • +19 more
    Apr 12, 2022

    Acute-graft-versus-host Disease, Steroid Refractory Acute GVHD, Graft-versus-host-disease Trial (Glassia)

    No longer available
    • Acute-graft-versus-host Disease
    • +7 more
    • (no location specified)
    Sep 30, 2020

    Hemophilia A, Hemophilia B Trial in China (Recombinant human activated coagulation factor VII for injection)

    Recruiting
    • Hemophilia A
    • Hemophilia B
    • Recombinant human activated coagulation factor VII for injection
    • Chongqing, Chongqing, China
    • +8 more
    Aug 2, 2022

    Liver Cirrhosis Trial in Berne (Rivaroxaban 10 mg Oral Tablet, Apixaban 2.5 mg Oral Tablet)

    Recruiting
    • Liver Cirrhosis
    • Rivaroxaban 10 mg Oral Tablet
    • Apixaban 2.5 mg Oral Tablet
    • Berne, Switzerland
      Department of Visceral Surgery and Medicine, University Hospital
    May 21, 2021

    Kidney Cancer Trial in Grenoble (CK2 and ATM inhibitors serine/ threonin Kinase combination, Sunitinib, Pazopanib)

    Recruiting
    • Kidney Cancer
    • CK2 and ATM inhibitors serine/ threonin Kinase combination
    • +3 more
    • Grenoble, France
      Grenoble Alps Hospital
    Jan 16, 2020

    Covid19 Trial in United Kingdom (Brensocatib, Placebo)

    Completed
    • Covid19
    • Aberdeen, United Kingdom
    • +15 more
    Aug 12, 2021

    Crohn Disease Trial in Ann Arbor (Low serine diet, High serine diet)

    Recruiting
    • Crohn Disease
    • Low serine diet
    • High serine diet
    • Ann Arbor, Michigan
      University of Michigan
    May 19, 2022

    Hereditary Sensory Neuropathy Type I Trial in London (L-serine, Placebo)

    Recruiting
    • Hereditary Sensory Neuropathy Type I
    • London, United Kingdom
      University College London
    Oct 31, 2023

    Cystic Fibrosis Trial in Tours (Pulmozyme)

    Completed
    • Cystic Fibrosis
    • Tours, France
      University Hospital - Tours
    Feb 28, 2022

    Alpha1-antitrypsin Deficiency Trial in Canada, United States (GLASSIA)

    Completed
    Has Results
    • Alpha1-antitrypsin Deficiency
    • GLASSIA
    • Tucson, Arizona
    • +17 more
    Sep 17, 2021

    Cognitive Function in Patients Treated With PCSK9 Inhibitors

    Completed
    • Cognitive Function
    • +2 more
    • PCSK9 inhibitor
    • Cee, A Coruña, Spain
    • +11 more
    Jan 13, 2023

    COPD, Alpha1-antitrypsin Deficiency Trial in Australia, Canada, United States (ARALAST NP 60 mg/kg, ARALAST NP 120 mg/kg,

    Terminated
    Has Results
    • Chronic Obstructive Pulmonary Disease
    • Alpha1-antitrypsin Deficiency
    • ARALAST NP 60 mg/kg
    • +4 more
    • Peoria, Arizona
    • +16 more
    Apr 17, 2021

    Healthy Volunteers Trial in Rennes (ANT3310, ANT3310-, Meropenem)

    Recruiting
    • Healthy Volunteers
    • Rennes, France
      Biotrial
    Jun 13, 2023

    Atherosclerosis Trial in Beijing (68Ga-FAPI)

    Recruiting
    • Atherosclerosis
    • Beijing, China
      Peking Union Medical College Hospital
    Sep 6, 2021

    Alpha 1-Antitrypsin Deficiency Trial in Australia, New Zealand (Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor, Dose

    Completed
    Has Results
    • Alpha 1-Antitrypsin Deficiency
    • Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor
    • Dose of 60 mg/kg alpha1-proteinase inhibitor
    • Adelaide, South Australia, Australia
    • +6 more
    Apr 17, 2021

    MDD Trial in Basel (D-serine, Placebo)

    Recruiting
    • Major Depressive Disorder
    • D-serine
    • Placebo
    • Basel, Baselstadt, Switzerland
      University of Basel, Department of Psychiatry (UPK)
    Oct 31, 2022

    BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

    Recruiting
    • BRAF V600E
    • Metastatic Colorectal Cancer
    • Beijing, Beijing, China
    • +33 more
    Dec 20, 2022

    Schizophrenia, Schizo Affective Disorder Trial in New York (D-serine, Placebo)

    Not yet recruiting
    • Schizophrenia
    • Schizo Affective Disorder
    • New York, New York
      New York State Psychiatric
    Jul 25, 2022

    NSCLC Trial in China (JAB 21822)

    Recruiting
    • Non-small Cell Lung Cancer
    • JAB 21822
    • Beijing, Beijing, China
    • +20 more
    Sep 26, 2022